134 related articles for article (PubMed ID: 36535053)
1. Accelerated ustekinumab dosing as rescue therapy in acute severe ulcerative colitis.
Affendi NANM; Ooi CJ; Hilmi IN
J Gastrointestin Liver Dis; 2022 Dec; 31(4):478-479. PubMed ID: 36535053
[No Abstract] [Full Text] [Related]
2. Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
Dalal RS; Ananthakrishnan AN; Hamilton MJ; Winter RW
Dig Dis Sci; 2021 Mar; 66(3):733-737. PubMed ID: 33569666
[No Abstract] [Full Text] [Related]
3. Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review.
Gisbert JP; García MJ; Chaparro M
J Crohns Colitis; 2023 Jun; 17(6):972-994. PubMed ID: 36652279
[TBL] [Abstract][Full Text] [Related]
4. An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
Ashat D; Jain A; Weaver KN; Long MD; Herfarth HH; Barnes EL
Dig Dis Sci; 2022 Dec; 67(12):5439-5443. PubMed ID: 36125593
[No Abstract] [Full Text] [Related]
5. Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.
Choy MC; Seah D; Faleck DM; Shah SC; Chao CY; An YK; Radford-Smith G; Bessissow T; Dubinsky MC; Ford AC; Churilov L; Yeomans ND; De Cruz PP
Inflamm Bowel Dis; 2019 Jun; 25(7):1169-1186. PubMed ID: 30605549
[TBL] [Abstract][Full Text] [Related]
6. Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
Govani SM; Berinstein JA; Waljee AK; Stidham RW; Higgins PDR; Hardiman KM
Dig Dis Sci; 2020 Jun; 65(6):1800-1805. PubMed ID: 31748921
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis.
Ochsenkühn T; Tillack C; Szokodi D; Janelidze S; Schnitzler F
United European Gastroenterol J; 2020 Feb; 8(1):91-98. PubMed ID: 32213052
[TBL] [Abstract][Full Text] [Related]
8. Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.
Sebastian S; Myers S; Argyriou K; Martin G; Los L; Fiske J; Ranjan R; Cooper B; Goodoory V; Ching HL; Jayasooriya N; Brooks J; Dhar A; Shenoy AH; Limdi JK; Butterworth J; Allen PB; Samuel S; Moran GW; Shenderey R; Parkes G; Lobo A; Kennedy NA; Subramanian S; Raine T
Aliment Pharmacol Ther; 2019 Sep; 50(6):675-683. PubMed ID: 31456297
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
Veyrard P; Pellet G; Laharie D; Nachury M; Juillerat P; Roblin X
Clin Gastroenterol Hepatol; 2023 May; 21(5):1354-1355.e2. PubMed ID: 35307594
[TBL] [Abstract][Full Text] [Related]
10. Dose-Intensified Infliximab Rescue Therapy for Severe Ulcerative Colitis Does Not Reduce Short-term Colectomy Rates or Increase Postoperative Complications.
Kosaraju RS; Wong DJ; Roth EM; Cataldo TE; Fabrizio AC; Crowell KT; Feuerstein JD; Messaris E
Dis Colon Rectum; 2022 Oct; 65(10):1232-1240. PubMed ID: 35714346
[TBL] [Abstract][Full Text] [Related]
11. [Acute severe ulcerative colitis treated with accelerated infliximab induction. Case report].
Fluxá D; Flores L; Kronberg U; Moreno M; Figueroa C; Ibáñez P; Lubascher J; Simian D; Quera R
Rev Med Chil; 2017 Aug; 145(8):1083-1088. PubMed ID: 29189869
[TBL] [Abstract][Full Text] [Related]
12. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
[TBL] [Abstract][Full Text] [Related]
13. Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis.
Jairath V; Chan K; Lasch K; Keeping S; Agboton C; Blake A; Patel H
Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):711-722. PubMed ID: 33599181
[No Abstract] [Full Text] [Related]
14. Intensification of maintenance therapy with infliximab in ulcerative colitis.
Casellas F
Rev Esp Enferm Dig; 2015 Sep; 107(9):525-6. PubMed ID: 26334457
[No Abstract] [Full Text] [Related]
15. Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab.
Fortuny Bauzá M; Cañete Pizarro F; Calm Salvans A; Calafat Sard M; Domènech Morral E
Gastroenterol Hepatol; 2022 Apr; 45 Suppl 1():11-12. PubMed ID: 34118322
[No Abstract] [Full Text] [Related]
16. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.
Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Danielsson A; Verbaan H; Hellström PM; Magnuson A; Curman B
Gastroenterology; 2005 Jun; 128(7):1805-11. PubMed ID: 15940615
[TBL] [Abstract][Full Text] [Related]
17. Biologic Therapy for Ulcerative Colitis.
Bhattacharya A; Osterman MT
Gastroenterol Clin North Am; 2020 Dec; 49(4):717-729. PubMed ID: 33121691
[TBL] [Abstract][Full Text] [Related]
18. Infliximab Rescue Therapy in Pediatric Severe Colitis.
Stewart S; Briggs KB; Dekonenko C; Fraser JA; Svetanoff WJ; Oyetunji TA; Bass JA; St Peter SD
J Pediatr Surg; 2023 Oct; 58(10):1893-1897. PubMed ID: 37349216
[TBL] [Abstract][Full Text] [Related]
19. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
20. One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study.
Dhaliwal J; McKay HE; Deslandres C; Debruyn J; Wine E; Wu A; Huynh H; Carman N; Crowley E; Church PC; Walters TD; Ricciuto A; Griffiths AM;
Aliment Pharmacol Ther; 2021 Jun; 53(12):1300-1308. PubMed ID: 33909911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
